ARCHIVES

ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay

This article is from The Cancer Letter archive.

Vol. 35 No. 28 | July 17, 2009

Download PDF Visit The Full Archive

Related Articles

House Aims to End Budget Markup Early; Natcher Sees Most Difficult Year

June 26, 1992

Bishop: Scientists Need Seat At NCI Executive Committee, More Voice In Decision Making

February 24, 1995

New Guidelines Developed For Cooperative Group Grant Review

August 17, 1979

NCI clinical trials cooperative group chairmen reject specimen bank contract proposal, endorse cooperative agreements;

January 2, 2004

Mothers’ Smoking, Depression Influences Teen Smoking

May 28, 2010

2,000 Breast Cancer Recurrence Biomarker Candidates Discovered

August 31, 2012